ERBB2 and neoplasm: The influence of the following clinicopathological parameters on the chance of developing distant metastasis was investigated: tumour size (continuous variable), tumour grade, vascular invasion, lymph node status, ER, PR, HER2 status and CDH5:HPA ratio.